Merck & Co. Pre-Tax Income decreased by 49.3% to $3.42B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $4.17B to $3.42B. Over 3 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 14.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
is_income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.72B | $5.27B | $3.43B | $4.86B | $4.49B | $3.58B | $3.51B | $3.65B | -$5.34B | $5.62B | $5.67B | $6.01B | $4.09B | $4.17B | $5.90B | $5.00B | $6.75B | $3.42B |
| QoQ Change | — | +206.7% | -34.8% | +41.6% | -7.7% | -20.1% | -2.0% | +3.9% | -246.2% | +205.3% | +0.9% | +5.9% | -31.9% | +2.0% | +41.6% | -15.3% | +34.9% | -49.3% |
| YoY Change | — | — | — | — | +161.3% | -32.0% | +2.3% | -24.9% | -218.9% | +56.9% | +55.3% | +212.6% | -27.2% | — | +4.1% | -16.8% | +64.9% | -18.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.